Nanomaterials for delivery of nucleic acid to the central nervous system (CNS)

被引：29

作者：

Wang, Danyang ^{[1
]}

Wu, Lin-Ping ^{[1
,2
]}

机构：

[1] Univ Copenhagen, Dept Pharm, Fac Hlth & Med Sci, Univ Pk 2, DK-2100 Copenhagen, Denmark

[2] Guangzhou RiboBio Co Ltd, Guangzhou 510663, Guangdong, Peoples R China

来源：

MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS | 2017年 / 70卷

关键词：

Nanomaterials; Nucleic acid; Blood brain barriers; Gene therapy; RNA interference; Drug delivery; Central nervous system; BLOOD-BRAIN-BARRIER; CELL-PENETRATING PEPTIDES; DRUG-DELIVERY; GENE DELIVERY; NANOGEL FORMULATIONS; CATIONIC COPOLYMERS; P-GLYCOPROTEIN; NANOPARTICLES; SIRNA; MECHANISM;

D O I：

10.1016/j.msec.2016.04.011

中图分类号：

TB3 [工程材料学]; R318.08 [生物材料学];

学科分类号：

0805 ; 080501 ; 080502 ;

摘要：

Billions of dollars have been invested in the therapeutic application of nucleic acid-based agents in humans in recent years. There are inspirable data from ongoing clinical trial for different diseases. However, in order to widely apply nucleic acid in prevention, diagnosis and treatment of age-related disease, such as neurodegeneration and disorders, suitable, safe and effective drug delivery nanocarriers have to been developed to overcome the blood brain barrier (BBB), which is the most inflexible barrier in human body. Here, we highlight the structure and function of barriers in the central nervous system (CNS) and summary several types of nanomaterials which can be potentially used in the brain delivery nucleic acid. (C) 2016 Elsevier B.V. All rights reserved.

引用

页码：1039 / 1046

页数：8

共 50 条

[21] Nucleic acid-based therapeutics for the treatment of central nervous system disorders
Mccartan, Robyn
Khorkova, Olga
Volmar, Claude-Henry
Wahlestedt, Claes
FRONTIERS IN GENETICS, 2023, 14
[22] Bevacizumab and central nervous system (CNS) hemorrhage
Letarte, Nathalie
Bressler, Linda R.
Villano, John L.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1561 - 1565
[23] Pharmacogenomics of Central Nervous System (CNS) Drugs
Cacabelos, Ramon
DRUG DEVELOPMENT RESEARCH, 2012, 73 (08) : 461 - 476
[24] Expression and functional analysis of nucleic acid sensors in cells of the central nervous system
Cox, Donal
Williams, Glyn
Kearney, Neil
Bowie, Andrew
Lynch, Marina
Dunne, Aisling
JOURNAL OF NEUROIMMUNOLOGY, 2014, 275 (1-2) : 83 - 83
[25] Recent progress in nanomaterials for nucleic acid delivery in cancer immunotherapy
Mei, Yeling
Wang, Ruibo
Jiang, Wei
Bo, Yang
Zhang, Tengfei
Yu, Junlin
Cheng, Ming
Wu, Yunzi
Cheng, Jianjun
Ma, Wang
BIOMATERIALS SCIENCE, 2019, 7 (07) : 2640 - 2651
[26] COMPARATIVE STUDIES ON THE TRANSPORT OF ISETHIONIC ACID AND TAURINE IN CENTRAL NERVOUS-SYSTEM (CNS)
IKAHEIMO, I
KUMPULAINEN, E
LAHDESMAKI, P
CELLULAR AND MOLECULAR BIOLOGY, 1982, 28 (06) : 529 - 533
[27] Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) - Implications for dietary recommendations
Guesnet, Philippe
Alessandri, Jean-Marc
BIOCHIMIE, 2011, 93 (01) : 7 - 12
[28] Therapeutic Delivery to Central Nervous System
Kunigelis, Katherine E.
Vogelbaum, Michael A.
NEUROSURGERY CLINICS OF NORTH AMERICA, 2021, 32 (02) : 291 - 303
[29] Drug delivery to the central nervous system
Elizabeth Nance
Suzie H. Pun
Rajiv Saigal
Drew L. Sellers
Nature Reviews Materials, 2022, 7 : 314 - 331
[30] Cell delivery to the central nervous system
Shoichet, MS
Winn, SR
ADVANCED DRUG DELIVERY REVIEWS, 2000, 42 (1-2) : 81 - 102

← 1 2 3 4 5 →